Clinical Trial Update: Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports results for long-acting methylphenidate in adults with ADHD, including efficacy and quality-of-life outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• methylphenidate (long-acting formulation) (methylphenidate)

Snippet

Sponsor: Janssen-Cilag Farmaceutica Ltda. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-07-23